Atlas Trials

GSNOR Therapeutics, Inc.

1 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch GSNOR Therapeutics, Inc.

RecordFirmDate
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of Cavosonstat Administered Twice Daily Compared With Placebo for 24 Weeks in Adult Subjects With Chronic Obstructive Pulmonary Disease (COPD) (NCT04600778)GSNOR Therapeutics, Inc.2021-02-03

Track GSNOR Therapeutics, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.